TEK2day FINANCE About TEK2day Finance

Duality Biotherapeutics Inc/ADR (DUTBF)

US Markets

Quarterly Financials

Metric2024-12-31
Revenue479.3M
Gross Profit125.1M
Operating Income(133.2M)
Net Income(484.0M)

Annual Financials

Metric2022-12-312023-12-312024-12-312025-12-31
Revenue1.6M1.8B1.9B1.9B
Gross Profit1.6M1.4B784.7M589.1M
Operating Income(369.7M)740.6M(203.4M)(455.0M)
Net Income(387.1M)(357.5M)(1.1B)(2.6B)
Want live quotes, estimates, SEC filings, and CEO analytics for DUTBF?
The free TEK2day terminal runs in your browser — type /DUTBF to get started.
Open DUTBF in the Terminal →